剑指中国生技巨头的《生物安全法案》 被美参议院推迟审议
Voice of America
据美国国会参议院消息人士周五(2月2日)指出，引发中国生技巨头公司股票大跌的《生物安全法案》已推迟了审议。
More Related News
Set News Language for United States
Primary Language (Mandatory)
Other Language[s] (Optional)
No other language available
Set News Language for World
Primary Language (Mandatory)
Other Language(s) (Optional)
Set News Source for United States
Primary Source (Mandatory)
Other Source[s] (Optional)
Set News Source for World
Primary Source (Mandatory)
Other Source(s) (Optional)